Psychometric Properties of a DSM-5-Based Screening Tool for Women's Perceptions of Premenstrual Symptoms

• Published in: Psychological reports Vol. 125; no. 2; pp. 1186 - 1217
• Main Authors: Richards, Meghan A., Oinonen, Kirsten A.
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.04.2022
• Subjects: Female; Humans; Premenstrual Dysphoric Disorder - diagnosis; Premenstrual Dysphoric Disorder - psychology; Prospective Studies; Psychometrics - methods; Reproducibility of Results; Retrospective Studies; Surveys and Questionnaires; PMDD; psychometrics; Premenstrual symptoms; screening; premenstrual syndrome
• ISSN: 0033-2941; 1558-691X
• DOI: 10.1177/0033294120979696

A premenstrual screening tool is needed when time constraints and attrition limit the feasibility of daily ratings. The present study examines the utility of a novel, 33-item, retrospective, dimensional, DSM-5-based, screening measure developed to explore women’s perceptions of premenstrual symptomatology. This is the first measure that examines perception of impairment for each DSM-5 symptom and assesses the frequency criterion. Participants (N = 331) reported symptoms ranging from none to a level consistent with a provisional DSM-5 diagnosis of Premenstrual Dysphoric Disorder (PMDD). Initial psychometric properties indicated a five-factor structure: (1) affective symptoms; (2) fatigue, sleep, and anhedonia; (3) symptom frequency; (4) impairment and severity of appetite change and physical symptoms; and (5) difficulty concentrating. The total symptom scale and the frequency, severity, and impairment subscales demonstrated high internal consistency. Strong correlations between this dimensional measure and other retrospective and prospective premenstrual symptom measures suggest strong convergent, concurrent, and predictive validity. Premenstrual symptom groups created using this screening measure (minimal, mild/moderate, severe) differed on other retrospective and prospective measures of premenstrual symptoms. There was evidence of divergent validity and lack of an acquiescence bias. We also report data describing women’s perceptions of the frequency, level of impairment, and level of severity for each DSM-5 PMDD symptom over a 12-month period and discuss implications for future research on premenstrual phenomenology. Initial evidence for the reliability and construct validity of this symptom screening measure suggests potential value for assessing premenstrual symptomatology in research and practice.